IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer (Q34992242)
scientific article
Language:
Current Data About IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer
(P31) (Q13442814)
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P50) (Q89006575)
(P1545) 1
(P1932) Roy S Herbst
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(Q17198867)
(P1545) 2
(P1932) Waun Ki Hong
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P304) 18-30
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P433) 5 Suppl 14
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P478) 29
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P577) Tuesday, October 1, 2002
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P921) (Q79460)
(P887)

(Q18554836)
(P887)

(Q422248)
(P887)

(P1433) (Q14330412)
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P1476) "IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer" (language: en)
(P248)
(P698) 12422310
(P813) Saturday, August 5, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1053/SONC.2002.35644
(P698) 12422310